If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Nobuo Tsukamoto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Immunotherapy Medicine & Life Sciences
Immunosuppressive Agents Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Tumor Microenvironment Medicine & Life Sciences
Dendritic Cells Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins Medicine & Life Sciences
Catenins Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2017

  • 774 Citations
  • 12 h-Index
  • 16 Article
  • 3 Chapter
1 Citation (Scopus)

CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients

Matsushita, M., Ozawa, K., Suzuki, T., Nakamura, M., Nakano, N., Kanchi, S., Ichikawa, D., Matsuki, E., Sakurai, M., Karigane, D., Kasahara, H., Tsukamoto, N., Shimizu, T., Mori, T., Nakajima, H., Okamoto, S., Kawakami, Y. & Hattori, Y., 2017 Sep 1, In : Blood Cancer Journal. 7, 9, e601.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Stem Cells
Therapeutics
T-Lymphocytes
10 Citations (Scopus)

Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma

Kinoshita, T., Kudo-Saito, C., Muramatsu, R., Fujita, T., Saito, M., Nagumo, H., Sakurai, T., Noji, S., Takahata, E., Yaguchi, T., Tsukamoto, N., Hayashi, Y., Kaseda, K., Kamiyama, I., Ohtsuka, T., Tomizawa, K., Shimoji, M., Mitsudomi, T., Asamura, H. & Kawakami, Y., 2017 Nov 1, In : European Journal of Cancer. 86, p. 15-27 13 p.

Research output: Contribution to journalArticle

Tumor Microenvironment
T-Lymphocytes
Adenocarcinoma
Non-Small Cell Lung Carcinoma
Immunosuppressive Agents

Personalized cancer immunotherapy: Immune biomarkers and combination immunotherapy

Kawakami, Y., Popivanova, B., Nuchsupha, S., Hayakawa, T., Nakamura, K., Nagumo, H., Katano, I., Kinoshita, T., Tsubota, K., Kamijuku, H., Kawamura, N., Miyazaki, J., Satomi, R., Sugiyama, J., Nishio, H., Noji, S., Kudo-Saito, C., Tsukamoto, N., Sakurai, T., Fujita, T. & 1 others, Yaguchi, T., 2016 Feb 22, Immunotherapy of Cancer: An Innovative Treatment Comes of Age. Springer Japan, p. 349-358 10 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Immunotherapy
Biomarkers
Neoplasms
T-Lymphocytes
Mutation

Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer

Kinoshita, T., Muramatsu, R., Fujita, T., Nagumo, H., Sakurai, T., Noji, S., Takahata, E., Yaguchi, T., Tsukamoto, N., Kudo-Saito, C., Hayashi, Y., Kamiyama, I., Ohtsuka, T., Asamura, H. & Kawakami, Y., 2016 Nov 1, In : Annals of oncology : official journal of the European Society for Medical Oncology. 27, 11, p. 2117-2123 7 p.

Research output: Contribution to journalArticle

Tumor-Infiltrating Lymphocytes
Non-Small Cell Lung Carcinoma
Habits
Smoking
Survival
1 Citation (Scopus)

Development of personalized combination cancer immunotherapy based on the patients’ immune status

Kawakami, Y., Qian, L., Kawamura, N., Miyazaki, J., Nagumo, H., Tsubota, K., Kinoshita, T., Nakamua, K., Ohmura, G., Satomi, R., Sugiyama, J., Nishio, H., Hayakawa, T., Popivanova, B., Nuchsupha, S., Hsin-Ju Liu, T., Kamijuku, H., Kudo-Saito, C., Tsukamoto, N., Sakurai, T. & 2 others, Fujita, T. & Yaguchi, T., 2015 Jan 1, Inflammation and Immunity in Cancer. Springer Japan, p. 255-266 12 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Immunotherapy
Neoplasms
T-Lymphocytes
Biomarkers
Immunosuppressive Agents